- Home
- ARCT vs CTKB Comparison
ARCT vs CTKB Comparison
Compare ARCT & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- CTKB
- Stock Information
- Founded
- ARCT 2013
- CTKB 1990
- Country
- ARCT United States
- CTKB United States
- Employees
- ARCT N/A
- CTKB N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ARCT Health Care
- CTKB Health Care
- Exchange
- ARCT Nasdaq
- CTKB Nasdaq
- Market Cap
- ARCT 526.5M
- CTKB 433.8M
- IPO Year
- ARCT N/A
- CTKB 2021
- Fundamental
- Price
- ARCT $7.34
- CTKB $5.46
- Analyst Decision
- ARCT Buy
- CTKB Hold
- Analyst Count
- ARCT 11
- CTKB 4
- Target Price
- ARCT $38.67
- CTKB $5.88
- AVG Volume (30 Days)
- ARCT 2.2M
- CTKB 1.2M
- Earning Date
- ARCT 11-10-2025
- CTKB 11-05-2025
- Dividend Yield
- ARCT N/A
- CTKB N/A
- EPS Growth
- ARCT N/A
- CTKB N/A
- EPS
- ARCT N/A
- CTKB N/A
- Revenue
- ARCT $97,601,000.00
- CTKB $196,828,000.00
- Revenue This Year
- ARCT N/A
- CTKB N/A
- Revenue Next Year
- ARCT $26.81
- CTKB $7.25
- P/E Ratio
- ARCT N/A
- CTKB N/A
- Revenue Growth
- ARCT N/A
- CTKB N/A
- 52 Week Low
- ARCT $7.26
- CTKB $2.37
- 52 Week High
- ARCT $24.17
- CTKB $7.30
- Technical
- Relative Strength Index (RSI)
- ARCT 26.87
- CTKB 75.57
- Support Level
- ARCT $7.93
- CTKB $4.57
- Resistance Level
- ARCT $9.29
- CTKB $4.96
- Average True Range (ATR)
- ARCT 0.57
- CTKB 0.31
- MACD
- ARCT -0.03
- CTKB 0.11
- Stochastic Oscillator
- ARCT 0.31
- CTKB 85.27
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.